Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Abrams

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cell Cycle (Georgetown, Tex.)|May 24, 2005
Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell lineJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.
Cell Cycle (Georgetown, Tex.)|May 27, 2005
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokinesJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.
Advances in Enzyme Regulation|March 27, 2007
Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistanceJames A McCubrey, Linda S Steelman, Richard A Franklin, et al.
Expert Opinion on Emerging Drugs|September 1, 2009
Emerging Raf inhibitorsJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Expert Opinion on Emerging Drugs|February 16, 2010
Emerging MEK inhibitorsJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Advances in Enzyme Regulation|July 21, 2006
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cell Cycle (Georgetown, Tex.)|May 24, 2005
Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell lineJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.
Cell Cycle (Georgetown, Tex.)|May 27, 2005
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokinesJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.
Advances in Enzyme Regulation|March 27, 2007
Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistanceJames A McCubrey, Linda S Steelman, Richard A Franklin, et al.
Expert Opinion on Emerging Drugs|September 1, 2009
Emerging Raf inhibitorsJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Expert Opinion on Emerging Drugs|February 16, 2010
Emerging MEK inhibitorsJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Advances in Enzyme Regulation|July 21, 2006
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Pageof 1